134 related articles for article (PubMed ID: 22699020)
1. St. John's wort significantly increased the systemic exposure and toxicity of methotrexate in rats.
Yang SY; Juang SH; Tsai SY; Chao PD; Hou YC
Toxicol Appl Pharmacol; 2012 Aug; 263(1):39-43. PubMed ID: 22699020
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats.
Chiang HM; Fang SH; Wen KC; Hsiu SL; Tsai SY; Hou YC; Chi YC; Chao PD
Toxicol Appl Pharmacol; 2005 Dec; 209(3):263-8. PubMed ID: 15936791
[TBL] [Abstract][Full Text] [Related]
3. Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: interactions between herbal extracts and drugs.
Fukunaga K; Orito K
J Vet Pharmacol Ther; 2012 Oct; 35(5):446-51. PubMed ID: 22091645
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in rats.
Lin SP; Tsai SY; Hou YC; Chao PD
J Agric Food Chem; 2009 Mar; 57(5):1854-9. PubMed ID: 19209930
[TBL] [Abstract][Full Text] [Related]
5. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
Jackson A; D'Avolio A; Moyle G; Bonora S; Di Perri G; Else L; Simiele M; Singh GJ; Back D; Boffito M
J Antimicrob Chemother; 2014 Jul; 69(7):1911-5. PubMed ID: 24610312
[TBL] [Abstract][Full Text] [Related]
7. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
[TBL] [Abstract][Full Text] [Related]
8. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
Bell EC; Ravis WR; Lloyd KB; Stokes TJ
Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
[TBL] [Abstract][Full Text] [Related]
9. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
10. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
Mai I; Bauer S; Perloff ES; Johne A; Uehleke B; Frank B; Budde K; Roots I
Clin Pharmacol Ther; 2004 Oct; 76(4):330-40. PubMed ID: 15470332
[TBL] [Abstract][Full Text] [Related]
11. Effect of St John's wort on bone formation in the orthopaedically expanded premaxillary suture in rats: a histological study.
Halicioglu K; Çörekçi B; Akkaş İ; Irgin C; Özan F; Yilmaz F; Türker A
Eur J Orthod; 2015 Apr; 37(2):164-9. PubMed ID: 24997024
[TBL] [Abstract][Full Text] [Related]
12. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.
Bauer S; Störmer E; Johne A; Krüger H; Budde K; Neumayer HH; Roots I; Mai I
Br J Clin Pharmacol; 2003 Feb; 55(2):203-11. PubMed ID: 12580993
[TBL] [Abstract][Full Text] [Related]
13. Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.
Hafner V; Jäger M; Matthée AK; Ding R; Burhenne J; Haefeli WE; Mikus G
Clin Pharmacol Ther; 2010 Feb; 87(2):191-6. PubMed ID: 19924124
[TBL] [Abstract][Full Text] [Related]
14. Drug interaction between St John's wort and zolpidem in healthy subjects.
Hojo Y; Echizenya M; Ohkubo T; Shimizu T
J Clin Pharm Ther; 2011 Dec; 36(6):711-5. PubMed ID: 21058968
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect.
Hatanaka J; Shinme Y; Kuriyama K; Uchida A; Kou K; Uchida S; Yamada S; Onoue S
Drug Metab Pharmacokinet; 2011; 26(6):551-8. PubMed ID: 21914965
[TBL] [Abstract][Full Text] [Related]
16. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.
Galeotti N; Vivoli E; Bilia AR; Vincieri FF; Ghelardini C
Biochem Pharmacol; 2010 May; 79(9):1327-36. PubMed ID: 20045676
[TBL] [Abstract][Full Text] [Related]
17. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
[TBL] [Abstract][Full Text] [Related]
19. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
[TBL] [Abstract][Full Text] [Related]
20. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
Schwarz UI; Hanso H; Oertel R; Miehlke S; Kuhlisch E; Glaeser H; Hitzl M; Dresser GK; Kim RB; Kirch W
Clin Pharmacol Ther; 2007 May; 81(5):669-78. PubMed ID: 17392718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
